Personal KinetiGraph® Clinical Validation Study

NCT05251701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2025-10-14

No results posted yet for this study

Summary

The purpose of this study is to clinically validate new measures of the Personal KinetiGraph® (PKG®).

Conditions

Interventions

DEVICE

Personal KinetiGraph® (PKG®) System

The PKG® System includes a wrist-worn device that records and measures movement patterns in conditions such as Parkinson's disease.

Sponsors & Collaborators

  • Global Kinetics Corporation

    lead INDUSTRY

Principal Investigators

  • Zoltan Mari, MD · Z Neurosciences, LLC.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2023-08-16
Completion
2025-09-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251701 on ClinicalTrials.gov